Experimental UVA Drug Reversed Paralysis and Vision Loss in Mice with MS-Like Disease, but Human Trials Still Needed
In a mouse study, UVA's experimental drug K-9 reversed paralysis and vision loss in an MS-like disease. It has not been tested for MS in humans.
Medical Daily ·